Level C· Early human research exploring benefitsCase Report / SeriesPubMedOpen access

Regenerative therapies for complex diabetic foot wounds: a therapeutic challenge.

Grillo VTRDS., Romio EA., Sousa CD., Ranite GG., da Silva WR., Melluci PL.

Case Report / Series on Diabetic Foot, Chronic Wound, published in J Vasc Bras (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
J Vasc Bras (2026)
Country
Brazil
Reported sample size
—
Source database
PubMed
PMID
42094715
PMCID
PMC13142167
DOI
10.1590/1677-5449.202500712

Abstract (original English)

Diabetic foot ulcers are a leading cause of morbidity, hospitalization, and nontraumatic lower-extremity amputation in patients with diabetes mellitus. Effective management of these wounds requires a multidisciplinary approach and combined therapies addressing infection control, perfusion optimization, and stimulation of tissue regeneration. This case report describes a patient with a severe infected neuroischemic foot ulcer treated with a sequential integrated strategy: infrapatellar endovascular revascularization, targeted antibiotic therapy, serial debridement, negative pressure wound therapy, application of an ovine-derived extracellular matrix, and autologous grafting of adipose tissue-derived mesenchymal stem cells. The treatment resulted in complete wound healing and limb preservation, with no recurrence after 7 months of follow-up. This case highlights the potential role of advanced regenerative therapies in the management of complex, refractory diabetic foot wounds, expanding therapeutic perspectives in the care of patients with diabetic foot. As úlceras do pé diabético representam uma das principais causas de morbidade, hospitalização e amputação não traumática de membros inferiores em pacientes com diabetes melito. O manejo eficaz dessas lesões requer abordagem multidisciplinar e terapias combinadas que contemplem controle infeccioso, otimização da perfusão e estímul

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research